The best cardiac and pulmonary rehabilitation program in Las Vegas, Nevada
MountainView Hospital’s Cardiopulmonary Rehabilitation Center offers a comprehensive lifestyle modification program for patients who experience pulmonary dysfunction or have had a catheter-based procedure for your heart. The individualized program encompasses every aspect necessary to ensure an enhanced understanding of the patient’s condition and improvement of their cardiorespiratory function. Our clinical professionals will work with you to work toward a healthier life.
Our goal is to help improve your understanding of your condition, enhance your ability to control symptoms and return you to your highest level of activity. Patients begin the program with an orientation that includes a physical evaluation and the development of a personal treatment plan. The plan is designed to assist you in achieving your goals and provide a foundation for maintaining achievable lifestyle changes. A family member or spouse is encouraged to participate in the educational sessions at no additional charge.
Patient’s progress is monitored and tracked using Scott Scare VersaCare, an industry leading system. Our medical management regimen includes:
- Stress management
- Weight management
- Treatment option information
- Smoking cessation
- Diagnosis education
Your exercise prescription is based on your diagnosis and any special needs you may have. You will learn how to exercise safely in a monitored environment. Individualized and group education is provided throughout the program so that each patient can learn more about cardiovascular and pulmonary disease and effective ways to manage risk factors associated with the conditions.
You will need a referral from your doctor for Outpatient Cardiac and/or Pulmonary Rehabilitation. For more information, call our Cardiac and/or Pulmonary Rehabilitation department. We also have an Inpatient Rehabilitation Unit and offer outpatient therapy services.
Patients should always discuss rehabilitation with their physician before starting this or any other exercise regimen. In order to begin rehab with our Cardiopulmonary Rehabilitation Program, you must obtain a physician’s prescription or referral. Medicare and most insurance companies cover Phase II Cardiac and Pulmonary Rehabilitation. Our staff can assist you with the insurance verification process prior to beginning rehabilitation.
For more information about our Cardiopulmonary Rehabilitation Center, call (702) 961-7620
The educational component of the program is designed to help each patient better understand their condition and treatment. Individual and group education is offered throughout the program. During the educational seminars, patients will receive detailed information on a variety of topics related to their recovery. All of the information provided to patients is supported by peer reviewed publications and certifying organizations.
Patients will also receive educational manuals upon entry into the program. The manuals are designed to assist patients and their families on the rehabilitation journey. The Cardiac and Pulmonary program manuals provide each patient with specific information about their condition, medication, benefits of exercise and nutrition recommendations. The Cardiopulmonary Rehabilitation team will also customize the program’s educational component to meet the needs of each individual patient.
Cardiac rehabilitation is a monitored exercise and education program that allows patients who have been diagnosed with a heart condition to confidently resume their normal activities as quickly as possible. Cardiac rehabilitation is designed for individuals who have been diagnosed or treated for:
- Severe coronary artery disease (CAD)
- Myocardial infarction (Heart attack)
- Coronary artery bypass graft (CABG)
- Chronic stable angina
- Congestive heart failure (CHF)
- Coronary revascularization (angioplasty, stent)
- Pre-/post heart transplantation
- Valve surgery
Pulmonary rehabilitation is a monitored exercise and education program for patients with chronic respiratory disease. The program is designed to improve your quality of life by enhancing your respiratory function through the implementation of healthy lifestyle modifications. Pulmonary rehabilitation is designed for those that have been diagnosed with conditions such as:
- Chronic obstructive pulmonary disease (COPD)
- Chronic bronchitis
- Pulmonary hypertension
- Pulmonary fibrosis
- Lung cancer and lung cancer surgery
- Pre-/post lung transplantation
Asthma is one of the top five chronic diseases globally. Severe asthma patients have frequent and life-threatening asthma attacks, and the highest doses of standard medications do not solve this issue. According to the Center for Disease Control and Prevention (CDC), asthma affects 20.4 million American adults and results in approximately 4,000 deaths and 1.7 million visits to emergency rooms. For this clinical need, MountainView Hospital is proud to offer bronchial thermoplasty as an asthma treatment for patients with severe asthma.
What is bronchial thermoplasty?
Bronchial thermoplasty is a bronchoscopic procedure for the treatment of severe persistent asthma in patients 18 years and older. Bronchial thermoplasty uses thermal energy to reduce the excessive airway smooth muscle responsible for airway constriction in asthma patients, thereby helping to gain long-lasting control in adults with severe asthma.
Bronchial thermoplasty is an asthma surgery that involves introducing a catheter into the patient’s lungs through a standard flexible bronchoscope inserted through the nose or mouth. The tip of the catheter expands to touch the walls of the airway. The catheter delivers controlled radiofrequency energy along the length of the airway walls in 10-second bursts, causing a reduction in excessive airway smooth muscle.
The procedure is typically done under moderate sedation in the hospital outpatient clinic, and the patient returns home the same day. In the period immediately following bronchial thermoplasty, there is an expected increase in the frequency and worsening of respiratory-related symptoms, which is normally expected. These events typically occur within a day of the procedure and resolve on average within seven days with standard care. Patients identified with increased risk factors associated with adverse events according to product labeling might be considered for inpatient stay.
The treatment is currently performed with three separate bronchoscopic sessions, each scheduled approximately three weeks apart and treating a different section of the lung. Each session lasts about an hour, and following hospital discharge and instructions from their treating physician, patients can usually resume their everyday activities at home.
Bronchial thermoplasty is approved by the Food and Drug Administration (FDA) and is indicated for the treatment of severe persistent asthma in patients whose asthma is not well controlled with inhaled corticosteroids and long-acting betaagonists.
Long-lasting control for asthma
The AIR2 Trial evaluated the safety and effectiveness of bronchial thermoplasty in patients with severe asthma, and demonstrated that treatment resulted in improved asthma quality of life, as well as in the following clinically meaningful benefits at one-year post-treatment:
- 32 percent reduction in asthma attacks
- 84 percent reduction in emergency room visits for respiratory symptoms
- 66 percent reduction in days lost from work/school or other daily activities due to asthma
Additionally, data from a recently concluded five-year study, the AIR2 Extension Study, has shown:
- Effectiveness of BT is maintained out to five years
- A 48 percent average decrease over five years in severe exacerbation event rates
- A reduction in severe exacerbation requiring oral corticosteroids
- A 88 percent average decrease over five years in the rate of ER visits for respiratory symptoms
- Long-term patient safety is maintained
Long-term safety and effectiveness
Bronchial thermoplasty has demonstrated a strong long-term safety profile with follow up out to five years in three consecutive clinical trials. In addition to safety, the five-year results from the AIR2 Trial also demonstrate long-term persistence of effect. Bronchial thermoplasty demonstrates:
- Long-term effectiveness maintained, demonstrated by reduction in the percentage of patients with severe exacerbations maintained out to five years
- Reduction in ER visits maintained out to five years
- Stable long-term safety profile (out to five years)
For more information about the bronchia thermoplasty procedure at MountainView Hospital, call us at (702) 962-5920.